SilcsBio provides computer-aided drug design solutions that dramatically accelerate and improve small molecule small molecule and biologic drug discovery pipelines.

Visit silcsbio

Revolve Biotechnologies has developed a protein & nucleic acid evolution platform for rapidly discovering optimal lead candidates from libraries of billions of variants.

Visit Revolve

ComputChem, a technology company building next generation platform solutions for in silico covalent drug design and lead optimization.

covalent drug design and lead optimization.covalent drug design and lead optimization.

Visit Computchem

rasio-therapeutics-raises-$1.5-million-to-advance-drug-development

Rasio addresses unmet patient needs through modeling of novel/deep cell binding regions. Rasio designs molecules to fit those regions and enhance treatment for cancer and other diseases.

Visit Rasio

Geminus is successfully developing Novel ARTs for treatment of AML.covalent drug design and lead optimization.covalent drug design and lead optimization.